- Home
- VANI vs RBA Comparison
VANI vs RBA Comparison
Compare VANI & RBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- RBA
- Stock Information
- Founded
- VANI 1998
- RBA 1958
- Country
- VANI United States
- RBA United States
- Employees
- VANI N/A
- RBA N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RBA Business Services
- Sector
- VANI Health Care
- RBA Consumer Discretionary
- Exchange
- VANI Nasdaq
- RBA Nasdaq
- Market Cap
- VANI 75.8M
- RBA 21.4B
- IPO Year
- VANI 2014
- RBA 1998
- Fundamental
- Price
- VANI $1.48
- RBA $118.26
- Analyst Decision
- VANI Strong Buy
- RBA Buy
- Analyst Count
- VANI 1
- RBA 5
- Target Price
- VANI $4.00
- RBA $120.40
- AVG Volume (30 Days)
- VANI 116.3K
- RBA 881.9K
- Earning Date
- VANI 11-12-2025
- RBA 11-07-2025
- Dividend Yield
- VANI N/A
- RBA 1.05%
- EPS Growth
- VANI N/A
- RBA 14.00
- EPS
- VANI N/A
- RBA 2.03
- Revenue
- VANI N/A
- RBA $4,418,000,000.00
- Revenue This Year
- VANI N/A
- RBA $6.23
- Revenue Next Year
- VANI N/A
- RBA $4.88
- P/E Ratio
- VANI N/A
- RBA $58.13
- Revenue Growth
- VANI N/A
- RBA 4.66
- 52 Week Low
- VANI $0.91
- RBA $78.08
- 52 Week High
- VANI $1.80
- RBA $118.79
- Technical
- Relative Strength Index (RSI)
- VANI 64.18
- RBA 61.87
- Support Level
- VANI $1.19
- RBA $116.12
- Resistance Level
- VANI $1.55
- RBA $118.91
- Average True Range (ATR)
- VANI 0.10
- RBA 1.70
- MACD
- VANI 0.03
- RBA 0.01
- Stochastic Oscillator
- VANI 82.93
- RBA 87.03
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About RBA RB Global Inc.
RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.